Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer.

Published on Dec 1, 2020in The Journal of Clinical Endocrinology and Metabolism5.399
· DOI :10.1210/CLINEM/DGAA597
Matthias Büttner4
Estimated H-index: 4
Laura D. Locati30
Estimated H-index: 30
+ 16 AuthorsSusanne Singer36
Estimated H-index: 36
PURPOSE Surgical complications such as hypoparathyroidism (HPT) or vocal cord palsy are seldom assessed when the quality of life (QOL) in thyroid cancer patients is investigated. The aim of this study was to measure the QOL difference in thyroid cancer survivors with and without HPT. METHODS Participants for this analysis were enrolled in 13 countries from a study that pilot-tested a thyroid cancer-specific QOL instrument. They were included if they had been diagnosed with thyroid cancer at least 9 months previously. QOL was measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC QLQ-C30) and some items on HPT symptoms (eg, tingling in fingers or toes). HPT status and other clinical data were extracted from the patients' medical charts. Comparisons of QOL domains between patients with and without HPT were performed using Mann-Whitney U test. The occurrence of HPT-related symptoms was compared using chi-square tests. Multiple ordinal regression analysis was performed to evaluate factors that might affect QOL. RESULTS Eighty-nine patients participated in this study, 17 of whom were considered to have HPT. Patients in the HPT group reported significantly reduced QOL in 9 of the 15 scales of the EORTC QLQ-C30 compared to patients without HPT. Regression analysis showed that HPT was independently negatively associated with various scales of the QLQ-C30. Both groups showed a high prevalence of typical HPT symptoms. CONCLUSION Thyroid cancer patients with HPT report significantly impaired QOL compared to thyroid cancer survivors without HPT. The assessment of HPT should be considered when measuring QOL in thyroid cancer patients.
📖 Papers frequently viewed together
2 Citations
1 Citations
1 Citations
#1Torben Harsløf (Aarhus University Hospital)H-Index: 14
#2Lars Rolighed (Aarhus University Hospital)H-Index: 15
Last. Lars Rejnmark (Aarhus University Hospital)H-Index: 63
view all 3 authors...
Purpose The reported incidence of post surgical hypoparathyroidism (HypoPT) varies greatly. Previous research suggests that the definition of HypoPT is not consistent in the literature. We therefore conducted a systematic review to investigate how HypoPT is defined and whether this definition, as well as the selected threshold for hypocalcemia affects the incidence.
11 CitationsSource
: The side effects of systemic chemotherapy used to treat cancer are often severe. For decades, oncologists have focused on treating the tumor, which may result in damage to the tumor‑bearing host and its immune system. Recently, much attention has been paid to the immune system of patients and its activation via biological therapies. Biological therapies, including immunotherapy and oncolytic virus (OV) therapy, are often more physiological and well tolerated. The present review elucidated how ...
135 CitationsSource
#1Martin Almquist (Lund University)H-Index: 29
#2Kerstin Ivarsson (Lund University)H-Index: 5
Last. Anders Bergenfelz (Lund University)H-Index: 33
view all 4 authors...
BACKGROUND: Permanent hypoparathyroidism remains the most common adverse outcome after total thyroidectomy, but long-term effects of hypoparathyroidism are unknown. The aim was to investigate mortality in patients with permanent hypoparathyroidism after total thyroidectomy. METHODS: Data from the Scandinavian Quality Register for Thyroid, Parathyroid and Adrenal Surgery were linked with the Swedish National Prescription Register for Pharmaceuticals and the Swedish National Inpatient Register. Pa...
34 CitationsSource
#1Lisa A. Orloff (Stanford University)H-Index: 26
#2Sam M. Wiseman (UBC: University of British Columbia)H-Index: 33
Last. Marilene B. Wang (UCLA: University of California, Los Angeles)H-Index: 35
view all 10 authors...
Background: Hypoparathyroidism (hypoPT) is the most common complication following bilateral thyroid operations. Thyroid surgeons must employ strategies for minimizing and preventing post-thyroidect...
69 CitationsSource
#1Gemma Marcucci (UniFI: University of Florence)H-Index: 13
#2Luisella Cianferotti (UniFI: University of Florence)H-Index: 25
Last. Maria Luisa Brandi (UniFI: University of Florence)H-Index: 68
view all 43 authors...
Hypoparathyroidism is a rare disease characterized by low serum calcium levels and absent or deficient parathyroid hormone level. Regarding the epidemiology of chronic hypoparathyroidism, there are limited data in Italy and worldwide. Therefore, the purpose of this study was to build a unique database of patients with chronic hypoparathyroidism, derived from the databases of 16 referral centers for endocrinological diseases, affiliated with the Italian Society of Endocrinology, and four centers ...
10 CitationsSource
#1Leyre Lorente-PochH-Index: 8
#2Juan J. SanchoH-Index: 19
Last. Antonio Sitges-SerraH-Index: 39
view all 4 authors...
Background: Parathyroid failure is the most common complication after total thyroidectomy but permanent impairment of the parathyroid function is unusual. Limited data is available assessing long-term follow-up, quality of life and complications occurring in patients with permanent hypoparathyroidism (PH). We aimed to assess the incidence of complications derived from PH status, their influence on the quality of life perceived by PH patients and its relation to standard medical treatment with ca...
10 CitationsSource
#1Barbara Gellén (MTA: Hungarian Academy of Sciences)H-Index: 2
#1Barbara Gellén (MTA: Hungarian Academy of Sciences)H-Index: 1
Last. Árpád Dobolyi (MTA: Hungarian Academy of Sciences)H-Index: 28
view all 4 authors...
Abstract Parathyroid hormone 2 receptor (PTH2R) and its ligand, tuberoinfundibular peptide of 39 residues (TIP39) have been implicated in the maintenance of homeostasis including body temperature in males. The system was recently shown to be activated in mothers. Therefore, we addressed some of its functions during pregnancy and lactation, comparing PTH2R-knockout (PTH2R-KO) mice with their wild type (WT) littermates. Core body temperature (Tc) was recorded via a telemetric device, anxiety was a...
9 CitationsSource
#1Tamara Vokes (U of C: University of Chicago)H-Index: 20
#2Michael Mannstadt (Harvard University)H-Index: 23
Last. John P. Bilezikian (Columbia University)H-Index: 99
view all 10 authors...
Context:Reduced health-related quality of life (HRQoL) is common in patients with hypoparathyroidism treated conventionally with calcium and active vitamin D supplements. Objective:To examine the effects of recombinant human parathyroid hormone [rhPTH(1-84)] on HRQoL as measured by the 36-Item Short-Form Health Survey (SF-36) during a multinational, randomized, placebo-controlled study. Patients:Adults (N = 122) with chronic hypoparathyroidism. Intervention(s):After an optimization period when c...
23 CitationsSource
#1Matthias BüttnerH-Index: 4
#2Thomas J. MusholtH-Index: 23
Last. Susanne SingerH-Index: 36
view all 3 authors...
Purpose Hypoparathyroidism is a rare endocrine disorder for which replacement therapy of the missing parathyroid hormone is not the standard therapeutic option. Current standard treatment consists of calcium and vitamin D supplementation. The intake of calcium and vitamin D supplementation can lead to complications and therefore might negatively influence patients’ quality of life.
34 CitationsSource
#1Roy Lirov (UM: University of Michigan)H-Index: 2
#2Francis P. Worden (UM: University of Michigan)H-Index: 37
Last. Mark S. Cohen (UM: University of Michigan)H-Index: 65
view all 3 authors...
Until recently, patients with advanced thyroid cancers had limited options for systemic treatment. With the introduction of tyrosine kinase inhibitors (TKIs) as a promising new class of targeted therapies for thyroid cancer, suddenly patients with advanced disease were given new options to extend survival. Guidelines worldwide have been updated to include general indications for these newer agents, but questions remain regarding which agent(s) to select, when to begin treatment, and how long the...
7 CitationsSource
Cited By1
#1Max A. Schumm (UCLA: University of California, Los Angeles)H-Index: 1
#2Melissa G. Lechner (UCLA: University of California, Los Angeles)H-Index: 16
Last. Michael W. Yeh (UCLA: University of California, Los Angeles)H-Index: 39
view all 8 authors...
Abstract: Objective To determine the frequency of levothyroxine (LT4) supplementation after therapeutic lobectomy for low-risk differentiated thyroid cancer (DTC). Methods Retrospective cohort study of adult patients with low-risk DTC confirmed on surgical pathology who underwent therapeutic lobectomy at a single institution from January 2016 through May 2020. Outcome measures were postoperative serum TSH levels and the initiation of LT4. Predictors of post-operative TSH >2 mIU/L and initiation ...